Literature DB >> 24487560

Harnessing the immune system to potentiate oncolytics.

Stephen Gottschalk1, Cliona M Rooney1.   

Abstract

Mesh:

Year:  2014        PMID: 24487560      PMCID: PMC3916053          DOI: 10.1038/mt.2013.295

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  6 in total

1.  Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients.

Authors:  Sari Pesonen; Iulia Diaconu; Lotta Kangasniemi; Tuuli Ranki; Anna Kanerva; Saila K Pesonen; Ulrike Gerdemann; Ann M Leen; Kalevi Kairemo; Minna Oksanen; Elina Haavisto; Sirkka-Liisa Holm; Aila Karioja-Kallio; Satu Kauppinen; Kaarina P L Partanen; Leena Laasonen; Tima Joensuu; Tuomo Alanko; Vincenzo Cerullo; Akseli Hemminki
Journal:  Cancer Res       Date:  2012-02-09       Impact factor: 12.701

Review 2.  New viruses for cancer therapy: meeting clinical needs.

Authors:  Tanner S Miest; Roberto Cattaneo
Journal:  Nat Rev Microbiol       Date:  2013-12-02       Impact factor: 60.633

Review 3.  Cell carriers for oncolytic viruses: Fed Ex for cancer therapy.

Authors:  Candice Willmon; Kevin Harrington; Timothy Kottke; Robin Prestwich; Alan Melcher; Richard Vile
Journal:  Mol Ther       Date:  2009-08-18       Impact factor: 11.454

4.  Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.

Authors:  Jeong Heo; Tony Reid; Leyo Ruo; Caroline J Breitbach; Steven Rose; Mark Bloomston; Mong Cho; Ho Yeong Lim; Hyun Cheol Chung; Chang Won Kim; James Burke; Riccardo Lencioni; Theresa Hickman; Anne Moon; Yeon Sook Lee; Mi Kyeong Kim; Manijeh Daneshmand; Kara Dubois; Lara Longpre; Minhtran Ngo; Cliona Rooney; John C Bell; Byung-Geon Rhee; Richard Patt; Tae-Ho Hwang; David H Kirn
Journal:  Nat Med       Date:  2013-02-10       Impact factor: 53.440

5.  T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy.

Authors:  Feng Yu; Xingbing Wang; Z Sheng Guo; David L Bartlett; Stephen M Gottschalk; Xiao-Tong Song
Journal:  Mol Ther       Date:  2013-10-17       Impact factor: 11.454

Review 6.  Oncolytic virotherapy.

Authors:  Stephen J Russell; Kah-Whye Peng; John C Bell
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.